TACTICAL Awards

2022

PCF Research Awards Notification:

Sign Up Here to be notified as research RFA’s become available.

PCF TACTICAL (Therapy ACceleration To Intercept CAncer Lethality) Awards
provide up to $10 million over three years to support large scale research projects led by qualified teams of academic scientists that specifically address the development of 21st Century therapies for lethal forms of prostate cancer.

“Supporting a focus on prostate cancer by talented, young investigators is critical to realizing PCF’s goal of accelerating breakthrough discoveries that can potentially end death and suffering from prostate cancer.”

Dr. Howard Soule,

PCF Executive Vice President and Chief Science Officer